BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
Hepatitis
,
Retina
,
Avian flu virus
,
Fenofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
gtp bind
Summary
General Info
Curated Studies
Most Correlated Studies
Colorectal cancer HCT 116 cells with RHOQ siRNA knockdown
Cervical carcinoma HeLa cells treated with MNK inhibitor eFT-508 and activated with PMA
Breast adenocarcinoma MDA-MB-231-Luc cells expressing RRAS2 shRNA
Uterus tissue from Folr4 knockout mice treated with folinic acid
Time-course studies of three cell wall interfering drugs on gene expression in yeast
Explore Curated Studies Results
Literature
Most Relevant Literature
Rnd2 differentially regulates oligodendrocyte myelination at different developmental periods.
The atypical Rho GTPase Rnd2 is critical for dentate granule neuron development and anxiety-like beh…
RND2 attenuates apoptosis and autophagy in glioblastoma cells by targeting the p38 MAPK signalling p…
Transcriptome profiling of colorectal tumors from patients with sepsis reveals an ethnic basis for v…
Pathophysiological functions of Rnd proteins.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation
EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Ant…
Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations
ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients
BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ